- Home
- BLRX vs VCSA Comparison
BLRX vs VCSA Comparison
Compare BLRX & VCSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- VCSA
- Stock Information
- Founded
- BLRX 2003
- VCSA 2009
- Country
- BLRX Israel
- VCSA United States
- Employees
- BLRX N/A
- VCSA N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- VCSA Computer Software: Prepackaged Software
- Sector
- BLRX Health Care
- VCSA Technology
- Exchange
- BLRX Nasdaq
- VCSA Nasdaq
- Market Cap
- BLRX 54.1M
- VCSA 38.3M
- IPO Year
- BLRX 2011
- VCSA N/A
- Fundamental
- Price
- BLRX $0.46
- VCSA $2.55
- Analyst Decision
- BLRX Strong Buy
- VCSA Buy
- Analyst Count
- BLRX 2
- VCSA 4
- Target Price
- BLRX $11.50
- VCSA $7.50
- AVG Volume (30 Days)
- BLRX 328.2K
- VCSA 82.7K
- Earning Date
- BLRX 11-18-2024
- VCSA 11-05-2024
- Dividend Yield
- BLRX N/A
- VCSA N/A
- EPS Growth
- BLRX N/A
- VCSA N/A
- EPS
- BLRX N/A
- VCSA N/A
- Revenue
- BLRX $17,048,000.00
- VCSA $1,014,965,000.00
- Revenue This Year
- BLRX N/A
- VCSA N/A
- Revenue Next Year
- BLRX N/A
- VCSA N/A
- P/E Ratio
- BLRX N/A
- VCSA N/A
- Revenue Growth
- BLRX N/A
- VCSA N/A
- 52 Week Low
- BLRX $0.43
- VCSA $2.07
- 52 Week High
- BLRX $1.93
- VCSA $13.00
- Technical
- Relative Strength Index (RSI)
- BLRX 31.02
- VCSA 37.49
- Support Level
- BLRX $0.43
- VCSA $2.47
- Resistance Level
- BLRX $0.56
- VCSA $3.05
- Average True Range (ATR)
- BLRX 0.06
- VCSA 0.23
- MACD
- BLRX -0.01
- VCSA -0.04
- Stochastic Oscillator
- BLRX 12.71
- VCSA 7.89
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About VCSA Vacasa Inc.
Vacasa Inc is a vacation rental management platform in North America, transforming the vacation rental experience by integrating purpose-built technology with expert local and national teams.